Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 21.89
-0.48 (-2.15%)
At close: Sep 11, 2026
SHA:688443 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -562.52 | -535.65 | -797.27 | -801.32 | -576.37 | -322.13 |
Depreciation & Amortization | 70.58 | 68.48 | 69.64 | 59.17 | 49.94 | 38.5 |
Other Amortization | 6.74 | 7.48 | 4.95 | 4.61 | 3.69 | 5.56 |
Loss (Gain) From Sale of Assets | 4.51 | 4.51 | 0 | - | -0 | - |
Asset Writedown & Restructuring Costs | 0.44 | 0.39 | 0.54 | 0 | 0 | 0.7 |
Loss (Gain) From Sale of Investments | -12.21 | -13.27 | -2.73 | -1.94 | -7.86 | -4.13 |
Provision & Write-off of Bad Debts | 0.16 | 0.48 | 0.63 | - | - | -0.03 |
Other Operating Activities | 34.65 | 31.9 | 29.51 | 34.01 | 33.99 | 32.15 |
Change in Accounts Receivable | -54.31 | 6.06 | -40.88 | 9.88 | -7.71 | -105.1 |
Change in Inventory | -80.69 | -45.01 | 4.69 | 1.85 | -22.67 | -17.81 |
Change in Accounts Payable | -17.66 | 136.72 | 1.73 | 51.1 | 55.87 | 131.8 |
Change in Other Net Operating Assets | 12.94 | - | 153.76 | 265.07 | 293.47 | 2.68 |
Operating Cash Flow | -597.36 | -337.91 | -575.44 | -377.58 | -177.64 | -237.82 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -90.15 | -85.42 | -45.32 | -90.98 | -146.21 | -112.7 |
Sale of Property, Plant & Equipment | 0.15 | 0.1 | 0.04 | - | - | 0 |
Investment in Securities | -616.41 | -264.2 | -382.28 | 211.6 | 194.2 | -409.24 |
Other Investing Activities | 11.66 | 8.83 | 0.14 | - | 3.4 | 1.12 |
Investing Cash Flow | -694.75 | -340.7 | -427.42 | 120.62 | 51.4 | -520.82 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | - | 73.32 |
Long-Term Debt Issued | - | 892.25 | 212.91 | 109.63 | 208.35 | 186.79 |
Total Debt Issued | 973.52 | 892.25 | 212.91 | 109.63 | 208.35 | 260.11 |
Short-Term Debt Repaid | - | - | - | - | - | -499.15 |
Long-Term Debt Repaid | - | -675.22 | -23.39 | -257.25 | -14.88 | -9.07 |
Lease Payments | -6.78 | -14.31 | -13.6 | -12 | -13.97 | -8.16 |
Total Debt Repaid | -796.75 | -675.22 | -23.39 | -257.25 | -14.88 | -508.22 |
Net Debt Issued (Repaid) | 176.77 | 217.02 | 189.52 | -147.62 | 193.48 | -248.11 |
Issuance of Common Stock | - | - | - | 3,308 | - | 1,000 |
Repurchase of Common Stock | - | -5.62 | -14.68 | - | - | - |
Common Dividends Paid | -31.37 | -30.51 | -28.67 | -35.02 | -32.1 | -21.59 |
Other Financing Activities | -4.37 | - | - | -25.41 | - | - |
Financing Cash Flow | 141.03 | 180.88 | 146.17 | 3,100 | 161.37 | 730.3 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.08 | 0.01 | - | - | - | - |
Net Cash Flow | -1,151 | -497.71 | -856.69 | 2,843 | 35.13 | -28.34 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -687.51 | -423.33 | -620.75 | -468.56 | -323.85 | -350.52 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -203.14% | -183.48% | -2062.65% | -38675.98% | -68143.75% | -894.41% |
Free Cash Flow Per Share | -1.87 | -1.15 | -1.69 | -1.46 | -1.18 | -1.27 |
Levered Free Cash Flow | -602.17 | -276.83 | -413.65 | -267.97 | -190.87 | -715.31 |
Unlevered Free Cash Flow | -591.97 | -257.2 | -395.59 | -246.1 | -170.4 | -695.05 |
Free Cash Flow After Leases | -694.29 | -437.63 | -634.35 | -480.56 | -337.82 | -358.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 9.19 | 7.79 | 4 | -21.69 | -57.48 | -17.5 |
Change in Working Capital | -139.72 | 97.77 | 119.3 | 327.89 | 318.97 | 11.57 |